{"id":"W2121410450","doi":"10.1136/annrheumdis-2013-204195","title":"Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Pfizer Pharmaceuticals; F. Hoffmann-La Roche; GlaxoSmithKline; Genentech; Bristol-Myers Squibb; AstraZeneca; Pfizer; Amgen; Eisai; Celltrion; Sanofi; Abbott Laboratories","keywords":"Golimumab; Medicine; Psoriatic arthritis; Placebo; Rheumatoid arthritis; Internal medicine; Ankylosing spondylitis; Methotrexate; Adverse effect; Arthritis; Surgery; Adalimumab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05076965,0.001843843,0.006414513,0.00438004,0.0004507174,0.002644975,0.001202088,0.001907013,0.00245919],"category_scores_gemma":[0.04456963,0.00118942,0.01437178,0.003003485,0.0004819972,0.0014541,0.001881934,0.001683706,0.0004003003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001292509,"about_ca_system_score_gemma":0.002301699,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001075113,"about_ca_topic_score_gemma":0.002366563,"domain_scores_codex":[0.9660769,0.02212768,0.004389598,0.001945532,0.004935423,0.0005248687],"domain_scores_gemma":[0.9382486,0.02483349,0.02556971,0.004493582,0.005524807,0.001329744],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.2695102,0.0006986879,0.07090186,0.03948338,0.4688455,0.0004971416,0.0003960898,0.003884353,0.005739965,0.0004889914,0.01278224,0.1267717],"study_design_scores_gemma":[0.1160988,0.0179137,0.28949,0.004028489,0.5275862,0.001171227,0.0001257886,0.002909624,0.002648668,0.0006635622,0.03706275,0.0003011571],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.3999641,0.5114598,0.01656611,0.002660669,0.001208017,0.007366808,0.05523867,0.001282417,0.004253455],"genre_scores_gemma":[0.8795995,0.05343517,0.01152647,0.002650233,0.001544979,0.004782262,0.04419085,0.0002658578,0.00200467],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.05076965,"threshold_uncertainty_score":0.2684987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06501003918027788,"score_gpt":0.3286827251089564,"score_spread":0.2636726859286785,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}